On the other hand, we found that the lower methylation of FBP1 in cancer tissues is associated with better overall survival for lung cancer patients, indicating a potential of methylation level in FBP1 promoter as a novel predictor for prognosis in non-small cell lung cancer patients. Here, FBP1 is linked to lung cancer.